Fujian Wanchen Biotechnology Co. Ltd (SHE:300972) — Market Cap & Net Worth
Market Cap & Net Worth: Fujian Wanchen Biotechnology Co. Ltd (300972)
Fujian Wanchen Biotechnology Co. Ltd (SHE:300972) has a market capitalization of $4.97 Billion (CN¥34.00 Billion) as of June 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #3628 globally and #535 in its home market, demonstrating a -3.61% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Fujian Wanchen Biotechnology Co. Ltd's stock price CN¥175.05 by its total outstanding shares 194216034 (194.22 Million). Review 300972 total debt and obligations to assess the company's total debt and financial obligations.
Fujian Wanchen Biotechnology Co. Ltd Market Cap History: 2021 to 2026
Fujian Wanchen Biotechnology Co. Ltd's market capitalization history from 2021 to 2026. Data shows growth from $443.23 Million to $4.97 Billion (43.73% CAGR).
Fujian Wanchen Biotechnology Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Fujian Wanchen Biotechnology Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.11x
Fujian Wanchen Biotechnology Co. Ltd's market cap is 0.11 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.25x
Fujian Wanchen Biotechnology Co. Ltd's market cap is 4.25 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $443.23 Million | $434.70 Million | $23.45 Million | 1.02x | 18.90x |
| 2022 | $342.18 Million | $549.26 Million | $47.74 Million | 0.62x | 7.17x |
| 2023 | $1.07 Billion | $9.29 Billion | -$82.93 Million | 0.11x | N/A |
| 2024 | $2.29 Billion | $32.33 Billion | $293.52 Million | 0.07x | 7.79x |
| 2025 | $5.71 Billion | $51.46 Billion | $1.34 Billion | 0.11x | 4.25x |
Competitor Companies of 300972 by Market Capitalization
Companies near Fujian Wanchen Biotechnology Co. Ltd in the global market cap rankings as of June 19, 2026.
Key companies related to Fujian Wanchen Biotechnology Co. Ltd by market ranking:
- Archer-Daniels-Midland Company (NYSE:ADM): Ranked #818 globally with a market cap of $33.40 Billion USD.
- Muyuan Foodstuff Co Ltd (SHE:002714): Ranked #998 globally with a market cap of $26.88 Billion USD ( CN¥183.71 Billion CNY).
- Bunge Limited (NYSE:BG): Ranked #1200 globally with a market cap of $21.79 Billion USD.
- Tyson Foods Inc (NYSE:TSN): Ranked #1591 globally with a market cap of $15.65 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #818 | Archer-Daniels-Midland Company | NYSE:ADM | $33.40 Billion | $75.10 |
| #998 | Muyuan Foodstuff Co Ltd | SHE:002714 | $26.88 Billion | CN¥33.63 |
| #1200 | Bunge Limited | NYSE:BG | $21.79 Billion | $112.58 |
| #1591 | Tyson Foods Inc | NYSE:TSN | $15.65 Billion | $55.46 |
Fujian Wanchen Biotechnology Co. Ltd Historical Marketcap From 2021 to 2026
Between 2021 and today, Fujian Wanchen Biotechnology Co. Ltd's market cap moved from $443.23 Million to $ 4.97 Billion, with a yearly change of 43.73%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥4.97 Billion | -12.94% |
| 2025 | CN¥5.71 Billion | +150.06% |
| 2024 | CN¥2.29 Billion | +114.20% |
| 2023 | CN¥1.07 Billion | +211.79% |
| 2022 | CN¥342.18 Million | -22.80% |
| 2021 | CN¥443.23 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Fujian Wanchen Biotechnology Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.97 Billion USD |
| MoneyControl | $4.97 Billion USD |
| MarketWatch | $4.97 Billion USD |
| marketcap.company | $4.97 Billion USD |
| Reuters | $4.97 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Fujian Wanchen Biotechnology Co. Ltd
Fujian Wanchen Biotechnology Co., Ltd., together with its subsidiaries, engages in the research, development, cultivation, production, and sale of edible fungi in China and internationally. The company offers enoki and golden enoki, white jade, crab, seafood, deer antler, oyster, and other mushrooms products, as well as flammulina velutipes, hydrangea edulis, and pleurotus eryngii. It is also inv… Read more